GeneralConnection.com ➔ Dictionary
Dictionary Search

factor ix

Synonyms

Noun

1. Christmas factor

2. factor IX, coagulation factor, clotting factor

Usage
A novel snake venom C-type lectin-like protein modulates blood coagulation by targeting von Willebrand factor and coagulation factor IX - Nature
Single-Dose Gene Therapy is Potentially Life-Changing for Adults with Hemophilia B - Penn Medicine
Idelvion: Cost, dosage, side effects, uses, interactions, and more - MedicalNewsToday
Gene Therapy for Hemophilia B Significantly Outperforms Factor IX Prophylaxis - MedPage Today
Clinical trial: Hemophilia B, (NCT06379789) - CRISPR Medicine - CRISPR Medicine News
An RNA aptamer exploits exosite-dependent allostery to achieve specific inhibition of coagulation factor IXa - PNAS
VisualAbstract: Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B is Superior to Prophylaxis - 2 Minute Medicine
Hemophilia - UF Health - University of Florida Health
Hemophilia B Market Size to Reach USD 24.7 Billion by 2035, Impelled by Advancements in Gene Therapy - BioSpace
Single-dose gene therapy is potentially life-changing for adults with hemophilia B - Penn Today
Biogen Idec to Present Data from Hematology Programs, Including ELOCTATE™ and ALPROLIX® at ASH Annual Meeting - Biogen
uniQure/ CSL Behring's Hemophilia Gene Therapy Shows Sustained Efficacy and Safety At Four Years - Yahoo Finance
CSL Behring's Gene Therapy HEMGENIX® (etranacogene dezaparvovec-drlb) Four Years Post-Infusion Data Continue to Show Sustained Efficacy and Safety in Adults with Hemophilia B - PR Newswire
Discovering cancer stem-like molecule, nuclear factor I X, using spatial transcriptome in gastric cancer - Wiley Online Library
Personal Story: Carrie | Hemophilia - Centers for Disease Control and Prevention (.gov)
Haemophilia B: My £2.6m blood has 'cured' my haemophilia - BBC
FDA Approves Marstacimab, First Weekly Sub-Q Option for Hemophilia B - AJMC
Pfizer to Discontinue Its Hemophilia B Gene Therapy - MedPage Today
Pre-clinical evaluation of an enhanced-function factor VIII variant for durable hemophilia A gene therapy in male mice - Nature
U.S. FDA Approves Pfizer’s HYMPAVZI™ (marstacimab-hncq) for the Treatment of Adults and Adolescents with Hemophilia A or B Without Inhibitors - BioSpace
Fig. 4. Intragenic polymorphisms of factor IX gene used for carrier... - ResearchGate
Fidanacogene Elaparvovec Shows Strong Results in Open-Label Phase 3 Study - AJMC
Pfizer Discontinues Hemophilia Gene Therapy Beqvez As Interest Wanes - Yahoo Finance
St. Jude's contribution to two new durable 'one-time' hemophilia drugs - St. Jude Children's Research Hospital
Pfizer: Beqvez Gene Therapy Decreases Bleeding Rates in Hemophilia B Patients - 2 Minute Medicine
uniQure successfully defends haemophilia gene therapy patent against Pfizer - JUVE Patent
CRISPR/Cas9 for hemophilia - Hemophilia News Today
Fig. 3. Deficiencias de Factor VIII (Hemofilia A) y Factor IX (Hemofilia B) - ResearchGate
Hympavzi Recommended for Approval in Europe for Severe Hemophilia A and B - Medscape
Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant - The New England Journal of Medicine
Hemophilia Patient Receives FDA Approved Gene Therapy - GlobeNewswire
of efficacy of extended half-life recombinant factor IX products in the prevention of bleeds. - ResearchGate
Mechanism of action for heparins. LMWH—low molecular weight heparin;... - ResearchGate
Haemophilia: Causes and advancements in treatment that you should know - Hindustan Times
Effects of codon optimization on coagulation factor IX translation and structure: Implications for protein and gene therapies - Nature
Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B - The New England Journal of Medicine
Systemic delivery of factor IX messenger RNA for protein replacement therapy - PNAS
Coagulation factor IX analysis in bioreactor cell culture supernatant predicts quality of the purified product - Nature
FDA OKs Second Gene Therapy for Hemophilia B - MedPage Today
Phase 3 Study of Recombinant Factor IX Fc Fusion Protein in Hemophilia B - The New England Journal of Medicine
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B - The New England Journal of Medicine
Pfizer Secures FDA Approval for Hemophilia B Gene Therapy, Launches Warranty - BioSpace
U.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B - Business Wire
Nuclear factor IX promotes glioblastoma development through transcriptional activation of Ezrin - Nature
Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector - Nature
EMA Authorizes Hemophilia B Gene Therapy - Medscape
Kallikrein directly interacts with and activates Factor IX, resulting in thrombin generation and fibrin formation independent of Factor XI - PNAS
Genome wide CRISPR/Cas9 screen identifies the coagulation factor IX (F9) as a regulator of senescence - Nature
Phase 1–2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B - The New England Journal of Medicine
Pfizer scores FDA nod for hemophilia B gene therapy, will charge $3.5M per dose - Fierce Pharma
Kallikrein directly interacts with and activates Factor IX, resulting in thrombin generation and fibrin formation independent of Factor XI - PNAS
FDA Approves Second Gene Therapy for Hemophilia B - Medscape
A Slow Embrace: Hemophilia's Gradual Adoption of Gene Therapy - CGTLive®
Ultrasound-targeted hepatic delivery of factor IX in hemophiliac mice - Gene Therapy - Nature
X-Linked Thrombophilia with a Mutant Factor IX (Factor IX Padua) - The New England Journal of Medicine
X-Linked Thrombophilia with a Mutant Factor IX (Factor IX Padua) - The New England Journal of Medicine
Mechanism of cancer-associated thrombosis (CAT). Tumour cells may be... - ResearchGate
Plasma Kallikrein Contributes to Coagulation in the Absence of Factor XI by Activating Factor IX - American Heart Association Journals
Plasma factor IX: The tip of the iceberg? - Sidonio - 2021 - Haemophilia - Wiley Online Library
Systemic delivery of factor IX messenger RNA for protein replacement therapy - PNAS
Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response - Nature
In Vivo Gene Therapy of Hemophilia B: Sustained Partial Correction in Factor IX-Deficient Dogs - Science | AAAS
What is the infected blood scandal and how much compensation will victims get? - BBC
Factor IX Deficiency and Prolonged Bleeding Time - The New England Journal of Medicine
Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B - The New England Journal of Medicine
Abstract MP57: Coagulation Factor IX and Incident Diabetes Risk: The REasons for Geographic and Racial Differences in Stroke (REGARDS) Study - American Heart Association Journals
Safety and activity of an engineered, liver-tropic adeno-associated virus vector expressing a hyperactive Padua factor IX administered with prophylactic glucocorticoids in patients with haemophilia B: a single-centre, single-arm, phase 1, pilot trial - The Lancet
Association Between Hepatic Triglyceride Content and Coagulation Factors: - American Heart Association Journals
Novel Insights and New Developments Regarding Coagulation Revealed by Studies of the Anti-Factor IXa (Activated Factor IX)/Factor X Bispecific Antibody, Emicizumab - American Heart Association Journals
Gene Therapy Used to Treat Hemophilia - National Institutes of Health (NIH) (.gov)
CSL Behring’s Gene Therapy HEMGENIX (etranacogene dezaparvovec): Four Years Post-Infusion Data Continue to Show Sustained Efficacy and Safety in Adults with Haemophilia B - Mynewsdesk
Low-dose AAVS3 gene therapy is efficacious for treating patients with hemophilia B - 2 Minute Medicine
Blood Test for Factor IX Now Available in Canada, Other Countries - Hemophilia News Today
Intellia opts out of hemophilia B gene editing work with Regeneron - Fierce Biotech
Safety and activity of an engineered, liver-tropic adeno-associated virus vector expressing a hyperactive Padua factor IX administered with prophylactic glucocorticoids in patients with haemophilia B: a single-centre, single-arm, phase 1, pilot trial - The Lancet
Factor IX Deficiency and Prolonged Bleeding Time - The New England Journal of Medicine
Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector - Nature
Anticoagulant Protein S Targets the Factor IXa Heparin-Binding Exosite to Prevent Thrombosis - American Heart Association Journals
Twenty-Four Novel Hemophilia B Mutations Revealed by Rapid Scanning of the Whole Factor IX Gene in a French Population Sample - Nature
Autologous and Heterologous Cell Therapy for Hemophilia B toward Functional Restoration of Factor IX - ScienceDirect.com
Real-world outcomes with recombinant factor IX Fc fusion protein (rFIXFc) prophylaxis: Longitudinal follow-up in a national adult cohort - Wiley Online Library
Explainer: Why Is Hemophilia B Called Christmas Disease? - Global Biotechnology Company
Fusion of engineered albumin with factor IX Padua extends half-life and improves coagulant activity - Wiley Online Library
Gene Therapy for Severe Hemophilia B Could Be More Cost Effective Than Current Treatments - Managed Healthcare Executive
Novel electric power-driven hydrodynamic injection system for gene delivery: safety and efficacy of human factor IX delivery in rats - Nature
Rebinyn Approval for Hemophilia B Expanded to Include Routine Prophylaxis - Medical Professionals Reference
In Vivo Demonstration in Humans That Large Postprandial Triglyceride-Rich Lipoproteins Activate Coagulation Factor VII Through the Intrinsic Coagulation Pathway - American Heart Association Journals
Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors - The New England Journal of Medicine
Haemophilia B Due to a De Novo Insertion of a Human-Specific Alu Subfamily Member within the Coding Region of the Factor IX Gene - Nature
Gene Therapy Helps Patients with Hemophilia - National Institutes of Health (NIH) (.gov)
Nanobodies against factor XI apple 3 domain inhibit binding of factor IX and reveal a novel binding site for high molecular weight kininogen - Wiley Online Library
Intrinsic Coagulation Pathway. The intrinsic system of coagulation,... - ResearchGate
Effects of preanalytical frozen storage time and temperature on screening coagulation tests and factors VIII and IX activity - Nature
Coagulation factors VII, IX and X are effective antibacterial proteins against drug-resistant Gram-negative bacteria - Nature
Increased mortality of COVID-19 infected diabetes patients: role of furin proteases | International Journal of Obesity - Nature
Rixubis (coagulation factor IX (recombinant)) for the Treatment of Haemophilia B - Clinical Trials Arena
Plasma Kallikrein Contributes to Coagulation in the Absence of Factor XI by Activating Factor IX - American Heart Association Journals
Phosphatidylethanolamine-phosphatidylserine binding synergy of seven coagulation factors revealed using Nanodisc arrays on silicon photonic sensors - Nature
Factor XI Deficiency: Practice Essentials, Background, Pathophysiology - Medscape
ASH: CSL, uniQure's gene therapy Hemgenix shows durable protection in hemophilia B - Fierce Pharma
Foreign Language Equivalents
Foreign Language Equivalents of 'factor ix'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
,   facto rix,   factr ix,   actor ix,   fsctor ix,   facctor ix,   gactor ix,   dactor ix,   factor ic,   factor i,   favtor ix,   facto ix,   factor ox,   factor iz,   factorix,   factpr ix,   factot ix,   facror ix,   faactor ix,   factor xi,   facttor ix,   factoe ix,   factir ix,   fator ix,   factor iix,   factro ix,   fcator ix,   facotr ix,   facter ix,   factor x,   factori x,   factoor ix,   facyor ix,   fctor ix,   afctor ix,   factor ux,   factor ixx,   factor ix,   facor ix,   factorr ix,   faxtor ix,   fatcor ix,   ffactor ix
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z